Open access
2,327
Views
3
CrossRef citations to date
0
Altmetric
Articles/Brief Reports
Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis
M Antonelou1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UKCorrespondence[email protected]
, A Abro1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UK
, R Heath1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UK
, A Iacovou1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UK
, C Ashley1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UK;2 Pharmacy Department, Royal Free Hospital, London, UK
, J Caplan3 Department of Renal Medicine, University Hospital Birmingham, Birmingham, UK
, MD Morgan3 Department of Renal Medicine, University Hospital Birmingham, Birmingham, UK
, S Logan3 Department of Renal Medicine, University Hospital Birmingham, Birmingham, UK
, L Harper3 Department of Renal Medicine, University Hospital Birmingham, Birmingham, UK
& AD Salama1 Department of Renal Medicine, Royal Free Hospital, University College London, London, UK
show all
Pages 135-141
|
Accepted 03 May 2021, Published online: 02 Sep 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.